Deferoxamine for Sickle Cell Chronic Leg Ulcer Treatment
NCT04058197
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Lack of enrollment
Conditions
Chronic Cutaneous Ulcer
Sickle Cell Disease
Interventions
DRUG:
Deferoxamine Product
OTHER:
Placebo
Sponsor
TauTona Group